We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$145M
AUM Growth
-$50.8M
(-26%)
Cap. Flow
-$60.8M
Cap. Flow
% of AUM
-41.91%
Top 10 Holdings %
Top 10 Hldgs %
65.8%
Holding
54
New
11
Increased
8
Reduced
13
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$7.45M |
| 2 |
Perrigo
PRGO
|
+$3.59M |
| 3 |
Medpace
MEDP
|
+$3.39M |
| 4 |
Philips
PHG
|
+$3.28M |
| 5 |
Actinium Pharmaceuticals
ATNM
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$14.8M |
| 2 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$7.86M |
| 3 |
Medtronic
MDT
|
+$6.51M |
| 4 |
Amgen
AMGN
|
+$6.09M |
| 5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
+$5.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.53% |
| 2 | Industrials | 6.55% |
| 3 | Consumer Discretionary | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FWP
26
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.79M | 1.23% |
12,158
-5,624
| -32% | -$791K |
|
|
AFAM
27
DELISTED
Almost Family Inc
AFAM
| $1.34M | 0.92% |
36,479
+8,027
| +28% | +$313K |
|
28
Viking Therapeutics
VKTX
$3.93B
| $1.19M | 0.82% |
849,905
+295,523
| +53% | +$391K |
|
|
ADMS
29
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.08M | 0.75% |
66,110
+9,610
| +17% | +$146K |
|
30
Spyre Therapeutics
SYRE
$8.68B
| $989K | 0.68% |
6,173
+498
| +9% | +$69.3K |
|
|
PFNX
31
DELISTED
Pfenex Inc.
PFNX
| $578K | 0.4% |
64,556
+15,464
| +32% | +$132K |
|
|
OASM
32
DELISTED
Oasmia Pharmaceutical AB
OASM
| $365K | 0.25% |
122,100
-900
| -0.7% | -$2.99K |
|
33
CALL
Abbott
ABT
$187B
| – | – |
-70,000
| Closed | -$2.75M |
|
|
34
Abbott
ABT
$187B
| – | – |
-104,550
| Closed | -$4.11M |
|
|
35
Amgen
AMGN
$212B
| – | – |
-36,000
| Closed | -$6.09M |
|
|
36
Biogen
BIIB
$30.4B
| – | – |
-61,000
| Closed | -$14.8M |
|
37
Bristol-Myers Squibb
BMY
$130B
| – | – |
-37,419
| Closed | -$2.75M |
|
38
PUT
Ecolab
ECL
$79.6B
| – | – |
-30,000
| Closed | -$3.56M |
|
39
IQVIA
IQV
$40.5B
| – | – |
-28,541
| Closed | -$1.86M |
|
40
PUT
Johnson & Johnson
JNJ
$643B
| – | – |
-55,000
| Closed | -$6.67M |
|
41
McKesson
MCK
$104B
| – | – |
-10,000
| Closed | -$1.87M |
|
|
42
Medtronic
MDT
$111B
| – | – |
-75,000
| Closed | -$6.51M |
|
|
NVO
43
PUT
Novo Nordisk
NVO
$225B
| – | – |
-140,000
| Closed | -$3.77M |
|
44
PUT
Pfizer
PFE
$144B
| – | – |
-189,720
| Closed | -$6.34M |
|
|
SAGE
45
PUT
DELISTED
Sage Therapeutics
SAGE
| – | – |
-56,800
| Closed | -$1.71M |
|
46
TriNet
TNET
$3.14B
| – | – |
-122,563
| Closed | -$2.55M |
|
|
MTEM
47
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-8,082
| Closed | -$847K |
|
|
NEOS
48
DELISTED
Neos Therapeutics, Inc
NEOS
| – | – |
-847,127
| Closed | -$7.86M |
|
|
FOMX
49
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – |
-405,374
| Closed | -$2.57M |
|
|
PETX
50
DELISTED
Aratana Therapeutics, Inc.
PETX
| – | – |
-59,869
| Closed | -$378K |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Sio Capital Management held 54 positions worth $145M, down 26% from $196M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Sio Capital Management withdrew a net $60.8M in Q3 2016, closing 22 positions and reducing 13 holdings. Its most notable exit was Biogen, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Sio Capital Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $7.3M.
- Sio Capital Management's largest Q3 2016 buy was Tabula Rasa HealthCare, Inc. Common Stock: 510,000 shares worth $7.3M.
- Sio Capital Management added most to Philips in Q3 2016, an estimated $3.28M increase.
- Sio Capital Management's biggest Q3 2016 reduction was Anthera Pharmaceuticals, Inc., cutting an estimated $5.15M.
- Sio Capital Management fully exited Biogen in Q3 2016, selling an estimated $14.8M.
- Sio Capital Management's ten largest holdings make up 66% of its $145M portfolio in Q3 2016.
- Sio Capital Management opened 11 new positions and closed 22 in Q3 2016.
- Sio Capital Management's portfolio value fell 26% quarter-over-quarter to $145M.
Based on Sio Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.